Open-Source Multinuclear Low-Field Preclinical MRI Scanner

开源多核低场临床前磁共振成像扫描仪

阅读:1

Abstract

Low-field MRI (B(0) ≤ 0.2 T) is emerging as a technology with the potential to revolutionize clinical diagnostics and patient monitoring. The reduction in magnetic field strength comes along with a decrease in the cost of the scanners and the infrastructure required for their operation. This, in turn, enables the development of compact, portable systems that extend imaging capabilities to locations and scenarios that were previously inaccessible. This democratization has empowered research groups worldwide to design and build their own scanners, resulting in a surge of new devices. However, the majority of low-field scanners are optimized for human studies, which limits their application in preclinical research and constrains the testing and development of contrast agents tailored for low-field regimes. In particular, hyperpolarized agents hold considerable promise for low-field MRI due to their capacity to enhance signal and provide metabolic imaging of living systems. This signal enhancement counteracts the inherently low signal-to-noise ratio of thermally polarized studies, which is the main limitation of low-field MRI. To exploit this potential, hyperpolarization studies frequently require the detection of X-nuclei, such as (13)C and (15)N, thereby emphasizing the need for versatile, multinuclear preclinical scanners. In this study, we present an open-source multinuclear low-field MRI scanner that has been specifically designed for hyperpolarized preclinical research. The device operates at 66 mT and allows the detection of (1)H, (23)Na, (13)C, and (15)N nuclei. Comprehensive documentation and complete CAD designs are provided to facilitate replication and adaptation by the research community. To illustrate the performance of the system, the results of the acquisition of NMR spectra from each nucleus are presented, as well as the first images obtained with the scanner. This platform aims to bridge the gap in preclinical low-field MRI, enabling rigorous in vivo testing of novel contrast agents and supporting broader innovation in the field.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。